Our analysis has revealed an entire catalog of gene candidates for further study, including those that correlate with survival outcomes, though an association with survival is not a prerequisite for being an effective target (i.e. estrogen receptor positivity in breast cancer). This evidence concerns the gene ESR1 and breast carcinoma.